Evidence suggests that the PI3K/Akt/mTOR and Hippo pathways are pivotal in conferring resistance of cancer cells to chemotherapy; hence, modulation of these pathways could represent a promising approach for cancer therapy [15, 16]. The gene discussed is AKT1; the disease is cancer.